Skip to Main Content

Sugammadex and Decreased Time to Extubation

Conditions

Diseases of the Cardiovascular System

Phase Pilot

What is the purpose of this trial?

The purpose of this study is to demonstrate faster time to extubation after arrival in the cardiothoracic intensive care unit (ICU) in patients undergoing isolated coronary artery bypass grafting (CABG) who receive Sugammadex as compared to placebo.

  • Trial with
    Merck Sharp & Dohme
  • Start Date
    09/17/2017
  • End Date
    06/29/2020
Trial Image

For more information about this study, contact:

Karen Stavris

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    06/09/2019
  • Study HIC
    #2000021124